Temsamani Karim Saad sold CDLX
March 4, 2024 · Form 4 insider transaction
Temsamani Karim Saad sold 34,515 shares of Cardlytics, Inc. at $7.89 per share, a transaction worth $272.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on March 1, 2024. The Reporting Person did not sell shares for any other purpose.; The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.66 to $8.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).